A Study of TYRA-300 in Children With Achondroplasia: BEACH301
Study sponsor: Tyra Biosciences, Inc · TYRA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2030-01Estimated
Enrollment · participants92Estimated
Source updated2026-11-18Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.